journal article·2021-05-10Open access

Special Issue: Nanomedicine Advances in Infectious Disease

Erica B. Peters, Rinti Banerjee

Abstract

RecommendationsT he emergence of Coronavirus Disease 2019 has made the scientific community exceedingly aware of the need for new approaches to address infectious diseases and enhance our preparation for future pandemics. These include preventive approaches in the form of prophylactic vaccines as well as therapeutic approaches in the form of new and repurposed drugs against specific infectious agents. Cenl to the efficacy of new drugs is their delivery to the desired site.Nanomedicine can assist this goal by utilizing nanotechnology to enhance therapeutic delivery and holds ample opportunities for biomaterial scientists and engineers.This special issue presents the latest advances in nanomaterials for managing infectious disease.The contributions are from a diverse global panel of experts leading efforts to enhance vaccine and antibiotic delivery as well as disrupt fungal and biofilm adhesions found in hospital-acquired infections.Fromen and colleagues 1 begin the issue with a timely review of opportunities for biomaterial-based immune engineering to mitigate the COVID-19 pulmonary immune response.They suggest nanomedicine approaches for tunable immune modulation of COVID-19 through more efficient, localized delivery that minimizes undesired effects of broad immunosuppression.The engineered particle formulations could be delivered by inhalation or injection with customizable biodegradability and allow codelivery of anti-inflammatory agents and particles sequestering inflammatory molecules to limit macrophage activation.The authors also provide a perceptive outlook for organ-on-a-chip model systems to help understand and develop therapeutics for long-term ailments associated with COVID-19.Vaccines offer prophylactic measures to prevent infectious disease.The role of biomaterial strategies for the delivery of vaccines has emerged to the forefront with the approval of lipid nanoparticle-based mRNA vaccines against SARS-nCOV2.However, issues exist with their equitable distribution among developing countries.One solution is to develop alternatives to traditional needle-based vaccines, which requires trained personnel for their administration.Mucosal vaccines are a promising option as they can raise systemic and local immunity and be delivered by needle-free methods.The Collier group 2 expands on this topic by introducing the biomaterials community to the field of subunit intranasal immunization in their review.Subunit vaccines are safer, cheaper, and more targeted alternatives to traditional, whole-organism vaccines.However, subunit vaccines have issues with immunogenicity and delivery, which may be resolved by utilizing nanomaterials.The authors identify key design criteria for delivering intranasal subunit antigens using polysaccharides, peptides and proteins,
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (13)

Show source-provided references
1. 10.1021/acsbiomaterials.0c0128710.1021/acsbiomaterials.0c01287 ↗
2. 10.1021/acsbiomaterials.0c0129110.1021/acsbiomaterials.0c01291 ↗
3. 10.1021/acsbiomaterials.0c0149610.1021/acsbiomaterials.0c01496 ↗
4. 10.1021/acsbiomaterials.0c0142910.1021/acsbiomaterials.0c01429 ↗
5. 10.1021/acsbiomaterials.0c0113210.1021/acsbiomaterials.0c01132 ↗
6. 10.1021/acsbiomaterials.0c0136310.1021/acsbiomaterials.0c01363 ↗
7. 10.1021/acsbiomaterials.0c0128410.1021/acsbiomaterials.0c01284 ↗
8. 10.1021/acsbiomaterials.0c0140610.1021/acsbiomaterials.0c01406 ↗
9. 10.1021/acsbiomaterials.0c0077610.1021/acsbiomaterials.0c00776 ↗
10. 10.1021/acsbiomaterials.0c0127110.1021/acsbiomaterials.0c01271 ↗
11. 10.1021/acsbiomaterials.0c0143310.1021/acsbiomaterials.0c01433 ↗
12. 10.1021/acsbiomaterials.0c0103910.1021/acsbiomaterials.0c01039 ↗
13. 10.1021/acsbiomaterials.0c0108410.1021/acsbiomaterials.0c01084 ↗